tirzepatide safety stats

semaglutide, tirzepatide, obesity treatment, prescription weight loss, GLP-1 / weight-loss drugs, GLP-1 receptor agonists — P

One Decision That Fixed Prescription Weight Loss

The single decision that fixed prescription weight loss was adopting semaglutide as the first-line GLP-1 agent; in 2024, patients on this regimen lost a median 12.5% of body weight in 16 weeks, outpacing diet-only controls. Medical Disclaimer: This article is for informational purposes only and does not constitute medical